Premium
Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis
Author(s) -
Baskol Gulden,
Baskol Mevlut,
Yurci Alper,
Ozbakir Omer,
Yucesoy Mehmet
Publication year - 2006
Publication title -
cell biochemistry and function
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.933
H-Index - 61
eISSN - 1099-0844
pISSN - 0263-6484
DOI - 10.1002/cbf.1224
Subject(s) - malondialdehyde , ulcerative colitis , paraoxonase , medicine , oxidative stress , antioxidant , chemistry , endocrinology , gastroenterology , biochemistry , disease
This study was designed to evaluate the oxidative and antioxidative status in patients with ulcerative colitis by detecting antioxidant enzyme paraoxonase 1 activity together with the level of a well‐known marker of oxidative stress, malondialdehyde. Serum paraoxonase 1 activity and malondialdehyde levels were analysed in 30 patients with ulcerative colitis and 30 controls using a spectrophotometric method; correlation analysis was made between these variables. Serum malondialdehyde levels were higher in the ulcerative colitis group (median: 2.5, range: 0.5–9.4 nmol ml −1 ) than among the controls (median:1.1, range: 0.5–2.3 nmol ml −1 ; p < 0.001) whereas paraoxonase 1 activities were lower in the ulcerative colitis group (median: 158.4, range: 61.6–264.1 U l −1 ) than in the control group (median: 233.3, range: 114.4–431.0 U l −1 ; p < 0.001). There was no correlation between serum malondialdehyde level, paraoxonase 1 activity and disease activity. (1) Increased reactive oxygen metabolites levels in ulcerative colitis may result in a pro‐oxidation environment, which in turn could result in decreased antioxidant paraoxonase 1 activity and increased malondialdehyde levels, (2) increased cytokines may be a possible cause of decreased paraoxonase 1 activity and (3) decreased serum paraoxonase 1 activity may be a part of an inflammatory response. Copyright © 2005 John Wiley & Sons, Ltd.